The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
GBS is a rare disorder where the immune system attacks the peripheral nervous system which carries signals from the brain and spinal cord to the rest of the body, causing muscle weakness and paralysis ...
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
Abstract Research of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia (FM), two acquired chronic illnesses affecting mainly females, has failed to ascertain their frequent ...
ONAPGOis the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s ...
Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...
Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...
Every year, thousands of people die from overdosing on opioids in the United States. But a new non-opioid pain medication, ...
Researchers are paving the way for the design of bionic limbs that feel natural to users. They demonstrate the connection ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...
In recent weeks, reports have been circulating about severe reactions in people who've taken over-the-counter vitamin B6 ...